Technological and computing advances have enabled the generation of vast amounts of translational data for the discovery of biomarker signatures of disease and drug response. However, leveraging these data within clinical trials remains a challenge. Data Management teams need to contend with new data types and multiple data vendors providing data without standardized formats. Bioinformatics and data science teams are often faced with time-consuming processes requiring that they spend the majority of their time gathering, cleaning and validating data to create the analysis dataset, leaving little time for the in-depth analysis that can lead to valuable insights.
In this webinar we will demystify the inclusion of omics data in your clinical trials. Industry experts will discuss key challenges, propose best practices and share success stories illustrating how incorporating translational omics data into clinical development yielded novel insights and improved patient/study outcomes.
Who Should Attend:
- Data Management teams
- Scientific teams: Translational Medicine, Precision Medicine, Biomarker Discovery